| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 非免疫规划疫苗(元) | 1,051,603,657.29 | - | 1,308,081,995.46 | - | 2,093,506,305.18 |
| 技术服务费(元) | 2,817,057.49 | 201,208,839.13 | 8,474,043.79 | 11,024,348.53 | 4,076,816.71 |
| 免疫规划疫苗(元) | 42,854,287.42 | - | 58,455,589.45 | - | 63,781,825.01 |
| 中间产品(元) | 53,940,191.72 | 60,260,245.18 | 44,630,793.76 | 17,217,232.62 | 3,003,030.07 |
| 自主疫苗(元) | - | 2,542,114,326.59 | - | 4,077,615,026.94 | - |
| 营业成本(元) | |||||
| 非免疫规划疫苗(元) | 265,070,573.78 | - | 215,549,994.15 | - | 214,955,218.31 |
| 技术服务费(元) | 1,526,331.49 | 19,708,072.41 | 1,016,317.96 | 7,955,635.93 | - |
| 免疫规划疫苗(元) | 38,189,057.46 | - | 45,517,362.82 | - | - |
| 中间产品(元) | 35,184,913.84 | 24,202,442.01 | 9,837,316.57 | 10,778,357.93 | - |
| 自主疫苗(元) | - | 509,740,645.82 | - | 571,902,165.53 | - |
| 毛利(元) | |||||
| 非免疫规划疫苗(元) | 786,533,083.51 | - | 1,092,532,001.31 | - | 1,878,551,086.87 |
| 技术服务费(元) | 1,290,726.00 | 181,500,766.72 | 7,457,725.83 | 3,068,712.60 | - |
| 免疫规划疫苗(元) | 4,665,229.96 | - | 12,938,226.63 | - | - |
| 中间产品(元) | 18,755,277.88 | 36,057,803.17 | 34,793,477.19 | 6,438,874.69 | - |
| 自主疫苗(元) | - | 2,032,373,680.77 | - | 3,505,712,861.41 | - |
| 毛利率(%) | |||||
| 非免疫规划疫苗(%) | 74.79 | - | 83.52 | - | 89.73 |
| 技术服务费(%) | 45.82 | 90.21 | 88.01 | 27.84 | - |
| 免疫规划疫苗(%) | 10.89 | - | 22.13 | - | - |
| 中间产品(%) | 34.77 | 59.84 | 77.96 | 37.40 | - |
| 自主疫苗(%) | - | 79.95 | - | 85.97 | - |
| 收入构成(%) | |||||
| 非免疫规划疫苗(%) | 91.35 | - | 92.14 | - | 96.73 |
| 技术服务费(%) | 0.24 | 7.18 | 0.60 | 0.27 | 0.19 |
| 免疫规划疫苗(%) | 3.72 | - | 4.12 | - | 2.95 |
| 中间产品(%) | 4.69 | 2.15 | 3.14 | 0.42 | 0.14 |
| 自主疫苗(%) | - | 90.67 | - | 99.31 | - |
| 毛利构成(%) | |||||
| 非免疫规划疫苗(%) | 96.95 | - | 95.19 | - | 100.00 |
| 技术服务费(%) | 0.16 | 8.07 | 0.65 | 0.09 | 0.00 |
| 免疫规划疫苗(%) | 0.58 | - | 1.13 | - | 0.00 |
| 中间产品(%) | 2.31 | 1.60 | 3.03 | 0.18 | 0.00 |
| 自主疫苗(%) | - | 90.33 | - | 99.73 | - |